Clinical Trials Directory

Trials / Completed

CompletedNCT02860858

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Department of Medical Services Ministry of Public Health of Thailand · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Objective: To evaluate the efficacy of intravitreal aflibercept injection on visual acuity in patients with symptomatic macular PCV.

Conditions

Interventions

TypeNameDescription
BIOLOGICALIntravitreous aflibercept injection

Timeline

Start date
2016-12-30
Primary completion
2018-08-30
Completion
2018-12-31
First posted
2016-08-09
Last updated
2020-10-23

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02860858. Inclusion in this directory is not an endorsement.

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV) (NCT02860858) · Clinical Trials Directory